A recent groundbreaking study published in The Lancet Obstetrics, Gynaecology & Women's Health has brought much-needed clarity and reassurance to pregnant women worldwide. The research, conducted by an international team of experts, has put an end to the anxiety surrounding the use of paracetamol during pregnancy. But here's where it gets controversial...
The Myth Busted: Paracetamol and Neurodevelopmental Risks
The study, described as the most rigorous to date, analyzed a vast amount of global data and concluded that paracetamol, when used as directed, does not increase the risk of autism, ADHD, or intellectual disability in children. This finding directly contradicts the high-profile claims made in the US last year, which suggested a possible link between paracetamol use during pregnancy and these neurodevelopmental disorders.
The researchers employed a systematic approach, focusing on high-quality studies with robust methodologies. A key aspect of their analysis was the use of sibling comparison studies, which compared siblings born to the same mother, with one pregnancy involving paracetamol use and the other not. This method helps control for shared genetics, family environment, and parental factors, ensuring a more accurate assessment of the drug's impact.
Across these sibling studies, the data was extensive, including assessments of autism, ADHD, and intellectual disability in hundreds of thousands of children. The results were clear: there was no increased risk associated with paracetamol use during pregnancy.
Addressing Confusion: The Role of Earlier Studies
The concerns about paracetamol and neurodevelopment gained momentum in 2025, with claims suggesting a potential link. However, the authors of the new review explain that many of these earlier studies had weaker designs and did not fully account for crucial factors such as maternal illness, fever, family history, and genetics, all of which can influence child development. By focusing on more rigorous studies and excluding lower-quality evidence, the researchers concluded that the earlier links were likely due to bias or unmeasured confounding factors, rather than a true causal effect of paracetamol.
The Impact on Pregnant Women: A Much-Needed Reassurance
Paracetamol is the most commonly recommended painkiller for pregnant women in the UK and is widely used to manage headaches, pain, and fever. It is generally considered safer than alternatives like ibuprofen or opioid painkillers. Moreover, doctors emphasize that untreated fever or severe pain during pregnancy can pose risks, including preterm birth and other complications. Therefore, avoiding paracetamol unnecessarily could potentially do more harm than good.
The findings align with the existing advice from reputable organizations such as the NHS, the Medicines and Healthcare products Regulatory Agency, and the Royal College of Obstetricians and Gynaecologists, all of which continue to recommend paracetamol as the first-line option during pregnancy when used at the lowest effective dose.
Expert Voices: Combating Misinformation
The study also comes at a time when there is an ongoing debate in the US, where claims about Tylenol (the US brand name for paracetamol) have been linked to wider misinformation about autism. Mel Merritt, Head of Policy and Campaigns at the National Autistic Society, warned last year about the real-world consequences of spreading fear among expectant parents. She emphasized that painkillers and vaccines do not cause autism, and large-scale studies have consistently shown no robust scientific evidence to support such claims. Merritt also highlighted the potential harm these narratives can cause, frightening pregnant women and devaluing autistic individuals and their families.
A Message for Expectant Mothers
For pregnant women contemplating the safety of paracetamol, this latest research provides a clear and reassuring message. Based on the best available evidence, taking paracetamol as advised during pregnancy is not associated with autism, ADHD, or intellectual disability. Health experts continue to endorse it as a safe and effective option for pain and fever relief.
If you have any concerns about medication during pregnancy, it's always best to consult your GP or midwife. This study offers strong reassurance, especially at a time when many expectant mothers have felt anxious and confused. It's time to put these myths to rest and focus on the well-being of both mothers and their babies.
